CVS HEALTH Corp

In its 13F for Q1 2024 (holdings as of March 31, 2024, filed May 3, 2024), CVS HEALTH Corp reported 5 stock positions worth $211.7 million. Its top holding was SS SPDR S&P 500 ETF Trust-US (SPY) at 71.1% of the portfolio, followed by Vanguard High DVD Yield ETF (VYM, 14.4%) and iShares Core High Dividend E (HDV, 14.2%). Its holdings were unchanged from Q4 2023.

Most Recent 13F
Q2 2026
Location
WOONSOCKET, RI
CIK
0000064803
Portfolio Value
$211.7M (Q1 2024)
SEC Filing
0000947871-24-000428 ↗ filed May 3, 2024

Holdings Value

0$50.0M$100.0M$150.0M$200.0M$250.0M Q1 2024: $211.7M $211.7M Q1 2024 Q2 2024: $216.8M Q2 2024 Q3 2024: $230.2M Q3 2024 Q4 2024: $233.7M Q4 2024 Q1 2025: $172.7M Q1 2025 Q2 2025: $190.6M Q2 2025 Q3 2025: $102.9M Q3 2025 Q4 2025: $135.3M Q4 2025 Q1 2026: $212.3M Q1 2026 Q2 2026: $225.2M Q2 2026

Holdings 5 stocks · $211.7M
SPY SS SPDR S&P 500 ETF Trust-US 71.12% 287,891 $150.6M No change
VYM Vanguard High DVD Yield ETF 14.40% 252,032 $30.5M No change
HDV iShares Core High Dividend E 14.22% 273,110 $30.1M No change
PRU Prudential Financial Inc. 0.15% 2,683 $315K No change
HCAT Health Catalyst Inc. 0.11% 32,273 $243K No change
Other holdings (1): bonds, preferreds, convertibles and warrants · $41K (not counted above)
SecurityClassShares / PrincipalValueChange
LMDWF Lumiradx Ltd. -CW26 *W EXP 09/28/202 5,352,106$41KNo change

Total filed on the 13F, all lines: $211.8M.

Portfolio Sells Q4 2023 → Q1 2024
None this quarter.

Portfolio Buys Q4 2023 → Q1 2024
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 21$225.2MIGSB, IGIB, IEI, SHY, USHY
Q1 2026 33$212.3MSPY, IEI, SHY, IGSB, AGG
Q4 2025 9$135.3MSPY, USHY, IGIB, JAAA, IGSB
Q3 2025 3$102.9MSPY, PRU, HCAT
Q2 2025 3$190.6MSPY, PRU, HCAT
Q1 2025 3$172.7MSPY, PRU, HCAT
Q4 2024 3$233.7MSPY, PRU, HCAT
Q3 2024 5$230.2MSPY, VYM, HDV, PRU, HCAT
Q2 2024 5$216.8MSPY, VYM, HDV, PRU, HCAT
Q1 2024 5$211.7MSPY, VYM, HDV, PRU, HCAT